Blau

CONTENTS
DiePharmazie 1/2016

Special issue: RNA-based therapeutics

Reviews

Rossbach O, Bindereif A: Eukaryotic non-coding RNAs: new targets for diagnostics and therapeutics?
doi: 10.1691/ph.2016.5736

Grünweller A, Hartmann RK: Chemical modification of nucleic acids as a key technology for the development of RNA-based therapeutics
doi: 10.1691/ph.2016.5738

Buchholz M: Circulating RNAs in medical diagnostics and as disease-relevant biomarkers
doi: 10.1691/ph.2016.5737

Kandil R, Merkel OM: Therapeutic delivery of RNA effectors: diseases affecting the respiratory system
doi: 10.1691/ph.2016.5740

Aigner A, Fischer D: Nanoparticle-mediated delivery of small RNA molecules in tumor therapy
doi: 10.1691/ph.2016.5735

Adams R, Steckel M, Nicke B, Pohlenz HD: RNAi as a tool for target discovery in early pharmaceutical research
doi: 10.1691/ph.2016.5471

Kloke BP, Kreiter S, Vormehr M, Diken M, Kuhn AN, Sahin U: Actively personalized cancer vaccines – the step into clinical application
doi: 10.1691/ph.2016.5739

 

 


Zurück